Microinjection of Transforming ras protein induces c-fos Expression

LITERATURE CITED

• Bar-Sagi, D., and J. R. Feramisco. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 223:1061–1068.
   Google Scholar
• Curran, T., R. Bravo, and R. Muller. 1985. Transient induction of c-fos and c-myc is an immediate consequence of growth factor stimulation. Cancer Surv. 4:655–681.
   PubMedGoogle Scholar
• Curran, T., and J. I. Morgan. 1985. Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science 229:1265–1268.
   PubMed Web of Science ®Google Scholar
• Curran, T., and N. M. Teich. 1982. Identification of a 39,000 dalton protein in cells transformed by the FBJ osteosarcoma virus. Virology 116:221–235.
   PubMed Web of Science ®Google Scholar
• Curran, T., C. Van Beveren, N. Ling, and I. M. Verma. 1985. Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein. Mol. Cell. Biol. 5:167–172.
   PubMedGoogle Scholar
• Doolittle, R. F., M. W. Hunkapiller, L. E. Hood, S. G. Devare, K. C. Robbins, S. A. Aaronson, and H. N. Antoniades. 1983. Simian sarcoma virus oncogene, v-sis, is derived from the gene (genes) encoding platelet-derived growth factor. Science 221:275–277.
   PubMed Web of Science ®Google Scholar
• Downward, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessmger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequence. Nature (London) 307:521–527.
   PubMed Web of Science ®Google Scholar
• Feramisco, J. R., M. Gross, T. Ramata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109–117.
   PubMed Web of Science ®Google Scholar
• Furth, M. E., L. J. Davis, B. Fleurdelys, and E. M. Scolnick. 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43:294–304.
   PubMed Web of Science ®Google Scholar
• Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311:433–438.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid transient expression of the c-fos gene and protein. Nature (London) 312:711–716.
   PubMed Web of Science ®Google Scholar
• Kung, H.-F., M. R. Smith, E. Bekesi, V. Manne, and D. W. Stacey. 1986. Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins. Exp. Cell Res. 162:363–371.
   PubMedGoogle Scholar
• Manne, V., E. Bekesi, and H.-F. Kung. 1985. Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity. Proc. Natl. Acad. Sci. USA 82:376–380.
   PubMed Web of Science ®Google Scholar
• Morgan, J. I., and T. Curran. 1986. Role of ion flux in the control of c-fos expression. Nature (London) 322:552–555.
   PubMed Web of Science ®Google Scholar
• Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH3T3 cells. Nature (London) 313:241–243.
   PubMed Web of Science ®Google Scholar
• Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312:716–720.
   PubMed Web of Science ®Google Scholar
• Papageorge, A. G., B. M. Willumsen, M. Johnsen, H.-F. Kung, D. W. Stacey, W. C. Vass, and D. R. Lowy. 1986. A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene. Mol. Cell. Biol. 6:1843–1846.
   PubMedGoogle Scholar
• Reddy, E. P., R. K. Reynolds, E. Santos, and M. Barbacid. 1982. A point mutation is responsible for the aquisition of transforming properties by the T-24 human bladder carcinoma oncogen. Nature (London) 300:149–152.
   PubMed Web of Science ®Google Scholar
• Santos, E., S. R. Tronick, S. A. Aaronson, S. Pulciani, and M. Barbacid. 1982. T-24 human bladder carcinoma oncogene is an activated form of the normal homologue of BALB and Harvey-MSV transforming gene. Nature (London) 298:343–347.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., C. W. Rettenmier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665–676.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature (London) 320:540–543.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., and H.-F. Kung. 1984. Transformation of NIH3T3 cells by microinjection of Ha-ras p21 proteins. Nature (London) 310:508–511.
   PubMed Web of Science ®Google Scholar
• Tabin, C. J., S. M. Bradley, C. I. Bargmann, R. A. Weinberg, A. G. Papageorge, E. M. Scolnick, R. Dahr, D. R. Lowy, and E. H. Chang. 1982. Mechanism of activation of a human oncogene. Nature (London) 300:143–149.
   PubMed Web of Science ®Google Scholar
• Waterfield, M. D., G. T. Scrace, N. Whittle, P. Stroobant, A. Johnsson, A. Wasteson, B. Westermark, C.-H. Heldin, J. S. Huang, and T. F. Deuel. 1983. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (London) 304:35–39.
   PubMed Web of Science ®Google Scholar